19053 Investors following Orchid Chemical. Share this News with them.
0
Like this story, share it with millions of investors on M3
Orchid Chemicals gets $1.5 m milestone payment from Merck
Orchid Chemicals & Pharmaceuticals has received initial USD 1.5 million in milestone payments from Merck & Co as its research programme with the pharma major for anti-infection drugs has completed a pre-clinical milestone.
Orchid Chemicals & Pharmaceuticals has received initial USD 1.5 million in milestone payments from Merck & Co as its research programme with the pharma major for anti-infection drugs has completed a pre-clinical milestone.
Orchid and Merck had in 2008 entered into an agreement to focus on discovery, development and commercialisation of new medicines to treat bacterial and fungal infections.
As per the agreement, Orchid Chemicals is eligible to receive payments over USD 100 million upon reaching various research and development milestones. It will also receive significant royalties on worldwide net sales of any products commercialized under the agreement.
Orchid Chemicals had said on Monday that it received approval from banks to raise USD 100 million via external commercial borrowings [ECB] for redeeming USD 117 million of foreign currency convertible bonds [FCCB] due in February 2012.
Orchid Chemicals shares were trading up over 6% at Rs 132.25 on NSE in noon trade.
